Canada· CA-DIN-02469332
CUVPOSA
A glycopyrronium bromid product containing glycopyrrolate, registered in Canada by MEDEXUS PHARMACEUTICALS INC.. The same ATC class is registered in 12 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Glycopyrronium bromid is registered in 12 of 19 countries.
Countries holding a registration under ATC A03AB02 (glycopyrronium bromid), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Glycopyrronium bromid · ATC A03AB02
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- GLYCOPYRROLATE
- Manufacturer
- MEDEXUS PHARMACEUTICALS INC.
- Country
- Canada (CA)
- ATC code
- A03AB02
- ATC class
- Glycopyrronium bromid
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Glycopyrronium bromid in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomGlycopyrronium bromide 5mg/5ml oral solutionDrug Tariff Special Order
- United StatesCuvposaMerz Pharmaceuticals, LLC
- CzechiaAMIDIL AMIHALERZaklady Farmaceutyczne Polpharma SA, Starogard Gdański
- BelgiumAxhidroks 8 mg/gDr. Wolff Arzneimittel
- FinlandAxhidroxDr. August Wolff GmbH & Co. KG Arzneimittel
- GermanyAxhidroxDr. August Wolff Gmbh & Co. Kg Arzneimittel
- SwedenAxhidrox 2,2 mg/pumpning KrämDr. August Wolff GmbH & Co Arzneimittel
- IrelandAxhidrox 2.2 mg/pump actuation creamDr. August Wolff GmbH & Co. KG Arzneimittel
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Axhidrox, Glycopyrroniumbromid Accord
- Belgium · Axhidroks, Robinul
- Bulgaria · Axhidrox, Амидил Амихалер
- Cyprus · Glycopyrronium Bromide Accord, Robinul
- Czechia · Amidil Amihaler, Axhidrox
- Germany · Axhidrox, Glycopyrronium Axiromed
- Denmark · Axhidrox, Glycopirronium Medical Valley
- Estonia · Axhidrox
- Finland · Axhidrox, Glykopyrroniumbromidi Accord
- France · Glycopyrronium Biogaran, Glycopyrronium Wolff
- United Kingdom (Northern Ireland) · Assicco, Glycopyrrolate Mercury Pharmaceuticals
- Greece · Axhidrox, Glycopyrronium Verisfield
- Croatia · Axhidrox
- Hungary · Axhidrox, Rybrila
- Ireland · Axhidrox, Glycopyrronium Bromide Ethypharm
- Iceland · Seebri Breezhaler, Sialanar
- Italy · Axhidrox, Glicopirronio Bromuro Accord
- Liechtenstein · Seebri Breezhaler, Sialanar
- Lithuania · Akshidroz
- Luxembourg · Axhidroks, Robinul
- Latvia · Axhidrox
- Malta · Glycopyrronium Morningside
- Netherlands · Axhidrox, Dusmyla
- Norway · Axhidrox, Glycopirronium Medical Valley
- Poland · Amidil Amihaler, Axhidrox
- Portugal · Glicopirrónio Axidrox
- Romania · Axhidrox
- Sweden · Axhidrox, Glycopirronium Medical Valley
- Slovenia · Axhidrox
- Slovakia · Axhidrox
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/82ea3d2f-4f95-4256-9f67-aed90859d72f GET /v1/drugs/82ea3d2f-4f95-4256-9f67-aed90859d72f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02469332",
"form": "SOLUTION",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "A03AB02",
"schedule": [
"Prescription"
],
"drug_code": "95811",
"strengths": [
"1 MG"
],
"ahfs_class": null,
"substances": [
"GLYCOPYRROLATE"
],
"product_categorization": null
}See everything about glycopyrronium bromid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.